NCT06378281

Brief Summary

Understanding of informed consent is often limited in prison, due to unique challenges faced by detained people. This study will test a modified "teach-to-goal" informed consent process compared to standard procedures. Conducted within a larger study on psychiatric outcomes, it aims to enhance ethical practices for vulnerable populations.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started May 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
May 2024Sep 2026

First Submitted

Initial submission to the registry

April 18, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 22, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

May 1, 2024

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

2.4 years

First QC Date

April 18, 2024

Last Update Submit

March 13, 2026

Conditions

Keywords

Informed consentPrisonEthics

Outcome Measures

Primary Outcomes (1)

  • Understanding of the informed consent (binary)

    20 questions (true/false) evaluating whether the participant understood the information. A binary variable coded 1 if all questions are answered correctly and 0 otherwise will be computed.

    Immediately after the intervention

Secondary Outcomes (2)

  • Understanding of the informed consent (continuous)

    Immediately after the intervention

  • Evaluation of the informed consent

    Immediately after the intervention

Study Arms (2)

Standard informed consent

NO INTERVENTION

According to ethical requirements of Swiss Human Research Act, the interviewer will explain the nature of the study, its purposes, duration, the potential risks and benefits it entails, and study procedures. He will inform that study participation is voluntary and that participants may withdraw at any time. He will also explain that the study is independent from the prison authorities. Participants will then be given time to read the informed consent, or, if they are not able to read, it will be read to them by the interviewer. The interviewer will answer all questions.

Modified teach-to-goal informed consent

EXPERIMENTAL

The standard process will first be used. After that, the interviewer will ask participants to summarize the content of the informed consent. The interviewer will correct not-well understood components and ask questions about forgotten components. In case of misconceptions, the participant will be asked to summarize again the corresponding components. A list of key components to be addressed will be developed by study team members, including experts in prison research and ethics, based on components listed in Art. 16 of the Swiss Human Research Act. The material of the informed consent of the parent-randomized controlled trial will be used.

Other: Modified teach-to-goal informed consent

Interventions

Enhanced procedure to improve informed consent in vulnerable populations.

Modified teach-to-goal informed consent

Eligibility Criteria

Age18 Years - 65 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥ 18 years
  • good command of French
  • absence of acute psychiatric disorder
  • providing written informed consent for study participation in the parent-RCT

You may not qualify if:

  • \- none.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Geneva University Hospitals

Geneva, Canton of Geneva, 1211, Switzerland

NOT YET RECRUITING

Geneva University Hospitals

Geneva, Canton of Geneva, 1226, Switzerland

RECRUITING

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Stéphanie Baggio, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr. phil.

Study Record Dates

First Submitted

April 18, 2024

First Posted

April 22, 2024

Study Start

May 1, 2024

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Locations